Global Clinical Trial Imaging Market By Modality (PET, CT, MRI, X-Ray, Ultrasound, and Echocardiography), By Application, By Services, and By Region – Global Trends and Forecast Analysis, 2021-2033
Publish Date: 2025-02-17 | Format: PDF | Category: Healthcare and Pharmaceutical | Pages: 279
The global clinical trial imaging market was valued at USD 1.32 Billion in 2024 and is projected to reach USD 2.91 Billion by 2033 at a CAGR of around 8.21% between 2024 and 2033. Increase in usage of technology and enhanced power of computing are the major drivers for the global clinical trial imaging market growth. There has been a significant rise in R&D spending and investments for development for new drugs as well as for new therapies, resulting in new opportunities for clinical trial imaging market in coming years. There is significant augment in number of contract research organizations along with the pharmaceutical and biotechnology companies and this factor becoming the major factor for the escalating the clinical trial imaging market growth. The progression in technology enables the substantial improvements required and adoption of innovative techniques provide opportunities for start-ups and new service launch. The increase in an adoption of clinical trial imaging techniques to understand the complexity of cellularity, metabolism, and vascularity is expected to spike up the clinical trial imaging market demand.
The key restraints for the clinical trial imaging market are the high-cost machinery, implementation of the systems and the capital required but can be overcome by mounting demand of outsourcing of services by pharmaceuticals, biotechnology, and medical device manufacturer form service providers. The most challenging aspect of the market for boosting growth is the inaccessibility of trial protocols and poor quality of the clinical data registered but the emergence of regional and national registries have eased overcomes the aforementioned hurdles. Understanding the current market scenario, CROs collaborations are most expected to be favoured by government organizations because of cutting edge services offered by them. The global clinical trial imaging market is segmented on the basis of modality, application, service, and region.
The application of the imaging techniques has been used in the clinical and non-clinical trials since long time. Most of the clinical imaging techniques are used to obtain information about human physiology or anatomy that is scientifically defined, explained, and interpretable. The use of imaging systems is primarily in the fields of research and development, pharmaceutical and biotechnology, and medical. The clinical images provide a method to assess the mode of drug delivery, prevention, treatment, and identification of different medical conditions.
Application Segment Analysis
On the basis of application, the market is segmented into pharmaceutical, biotechnology, medical devices, and others. In clinical trial studies, medical imaging emerges as a critical endpoint across wide-ranging therapeutic areas such as neurology, musculoskeletal, and oncology thus others segment holds the largest market share in global clinical trial imaging market.
Modality Segment Analysis
On the basis of modality, the clinical trial imaging market is divided into PET, CT, MRI, X-Ray, ultrasound, and echocardiography. The main application of CT is during the screening of cancer tumors, injuries, and abnormalities while the major application of PET is during obtaining information about the function and metabolism of body organs. MRI provides proof of effects and efficacy of drugs and treatments and X-ray provides cross-sectional images of body. These key applications lead to increase in adoption of trial imaging techniques by pharmaceuticals, biotechnology, and CROs.
Service Segment Analysis
Based on service, the global clinical trial imaging market is classified into operational imaging services, trial design consulting services, and read analysis services. Among these operational imaging services holds the significant amount of market share as it comprises of core services provided by CROs.
Regional Analysis
The clinical trial imaging market is analysed across five regions including, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to holds the largest market share due to an increase in R&D investment and demand for new drugs for rising prevalence of chronic diseases with increasing population. The advancement in the health-care and investment provided by the government has played a main role in tackling the challenges and in attaining accomplishments. The Asia Pacific region is expected to project a swift growth during the forecast period due to the low cost of labor and public & private funding.
Competitive Scenario
The report covered the detailed competitive analysis including company profiles of the major industry players operating in the global clinical trial imaging market. Key players profiled in the report are Biotelemetry, Inc., Cardiovascular Imaging Technologies, LLC, Radiant Sage LLC, Worldcare Clinical, LLC, Intrinsic Imaging LLC, Bioclinica, Inc., Parexel International Corporation, Icon PLC, Biomedical Systems Corporation, Ixico PLC, and others.
Clinical Trial Imaging Market Report Scope
| Report Attribute | Details |
|---|---|
| Market Size Value in 2024 | USD 1.32 Billion |
| Revenue Forecast in 2033 | USD 2.91 Billion |
| Growth Rate | CAGR of 8.21% from 2025 to 2033 |
| Historic Period | 2021 - 2024 |
| Forecasted Period | 2025 - 2033 |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Regions Covered | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Countries Covered | U.S.; Canada; Mexico, UK; Germany; France; Spain; Italy; Russia; China; Japan; India; South Korea; Australia; Southeast Asia; Brazil; Argentina; Saudi Arabia; UAE; South Africa |
| Key companies profiled | Biotelemetry, Inc.; Cardiovascular Imaging Technologies, LLC; Radiant Sage LLC; Worldcare Clinical, LLC; Intrinsic Imaging LLC; Bioclinica, Inc.; Parexel International Corporation; Icon PLC; Biomedical Systems Corporation; Ixico PLC; Others |
| Customization | Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
The Global Clinical Trial Imaging Market report is segmented as follows:
By Modality,
- PET
- CT
- MRI
- X-Ray
- Ultrasound
- Echocardiography
By Application,
- Pharmaceutical
- Biotechnology
- Medical Devices
- Others
By Services,
- Operational Imaging Services
- Trial Design Consulting Services
- Read Analysis Services
By Region,
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Key Market Players,
- Biotelemetry, Inc.
- Cardiovascular Imaging Technologies, LLC
- Radiant Sage LLC
- Worldcare Clinical, LLC
- Intrinsic Imaging LLC
- Bioclinica, Inc.
- Parexel International Corporation
- Icon PLC
- Biomedical Systems Corporation
- Ixico PLC
- Others
Frequently Asked Questions
Research Objectives
- Proliferation and maturation of trade in the global Clinical Trial Imaging Market.
- The market share of the global Clinical Trial Imaging Market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Clinical Trial Imaging Market.
- Feasibility study, new market insights, company profiles, investment return, market size of the global Clinical Trial Imaging Market.
Chapter 1 Clinical Trial Imaging Market Executive Summary
- 1.1 Clinical Trial Imaging Market Research Scope
- 1.2 Clinical Trial Imaging Market Estimates and Forecast (2021-2033)
- 1.2.1 Global Clinical Trial Imaging Market Value and Growth Rate (2021-2033)
- 1.2.2 Global Clinical Trial Imaging Market Price Trend (2021-2033)
- 1.3 Global Clinical Trial Imaging Market Value Comparison, by Modality (2021-2033)
- 1.3.1 PET
- 1.3.2 CT
- 1.3.3 MRI
- 1.3.4 X-Ray
- 1.3.5 Ultrasound
- 1.3.6 Echocardiography
- 1.4 Global Clinical Trial Imaging Market Value Comparison, by Application (2021-2033)
- 1.4.1 Pharmaceutical
- 1.4.2 Biotechnology
- 1.4.3 Medical Devices
- 1.4.4 Others
- 1.5 Global Clinical Trial Imaging Market Value Comparison, by Services (2021-2033)
- 1.5.1 Operational Imaging Services
- 1.5.2 Trial Design Consulting Services
- 1.5.3 Read Analysis Services
Chapter 2 Research Methodology
- 2.1 Introduction
- 2.2 Data Capture Sources
- 2.2.1 Primary Sources
- 2.2.2 Secondary Sources
- 2.3 Market Size Estimation
- 2.4 Market Forecast
- 2.5 Assumptions and Limitations
Chapter 3 Market Dynamics
- 3.1 Market Trends
- 3.2 Opportunities and Drivers
- 3.3 Challenges
- 3.4 Market Restraints
- 3.5 Porter's Five Forces Analysis
Chapter 4 Supply Chain Analysis and Marketing Channels
- 4.1 Clinical Trial Imaging Supply Chain Analysis
- 4.2 Marketing Channels
- 4.3 Clinical Trial Imaging Suppliers List
- 4.4 Clinical Trial Imaging Distributors List
- 4.5 Clinical Trial Imaging Customers
Chapter 5 COVID-19 & Russia–Ukraine War Impact Analysis
- 5.1 COVID-19 Impact Analysis on Clinical Trial Imaging Market
- 5.2 Russia-Ukraine War Impact Analysis on Clinical Trial Imaging Market
Chapter 6 Clinical Trial Imaging Market Estimate and Forecast by Region
- 6.1 Global Clinical Trial Imaging Market Value by Region: 2021 VS 2023 VS 2033
- 6.2 Global Clinical Trial Imaging Market Scenario by Region (2021-2023)
- 6.2.1 Global Clinical Trial Imaging Market Value Share by Region (2021-2023)
- 6.3 Global Clinical Trial Imaging Market Forecast by Region (2024-2033)
- 6.3.1 Global Clinical Trial Imaging Market Value Forecast by Region (2024-2033)
- 6.4 Geographic Market Analysis: Market Facts and Figures
- 6.4.1 North America Clinical Trial Imaging Market Estimates and Projections (2021-2033)
- 6.4.2 Europe Clinical Trial Imaging Market Estimates and Projections (2021-2033)
- 6.4.3 Asia Pacific Clinical Trial Imaging Market Estimates and Projections (2021-2033)
- 6.4.4 Latin America Clinical Trial Imaging Market Estimates and Projections (2021-2033)
- 6.4.5 Middle East & Africa Clinical Trial Imaging Market Estimates and Projections (2021-2033)
Chapter 7 Global Clinical Trial Imaging Competition Landscape by Players
- 7.1 Global Top Clinical Trial Imaging Players by Value (2021-2023)
- 7.2 Clinical Trial Imaging Headquarters and Sales Region by Company
- 7.3 Company Recent Developments, Mergers & Acquisitions, and Expansion Plans
Chapter 8 Global Clinical Trial Imaging Market, by Modality
- 8.1 Global Clinical Trial Imaging Market Value, by Modality (2021-2033)
- 8.1.1 PET
- 8.1.2 CT
- 8.1.3 MRI
- 8.1.4 X-Ray
- 8.1.5 Ultrasound
- 8.1.6 Echocardiography
Chapter 9 Global Clinical Trial Imaging Market, by Application
- 9.1 Global Clinical Trial Imaging Market Value, by Application (2021-2033)
- 9.1.1 Pharmaceutical
- 9.1.2 Biotechnology
- 9.1.3 Medical Devices
- 9.1.4 Others
Chapter 10 Global Clinical Trial Imaging Market, by Services
- 10.1 Global Clinical Trial Imaging Market Value, by Services (2021-2033)
- 10.1.1 Operational Imaging Services
- 10.1.2 Trial Design Consulting Services
- 10.1.3 Read Analysis Services
Chapter 11 North America Clinical Trial Imaging Market
- 11.1 Overview
- 11.2 North America Clinical Trial Imaging Market Value, by Country (2021-2033)
- 11.2.1 U.S.
- 11.2.2 Canada
- 11.2.3 Mexico
- 11.3 North America Clinical Trial Imaging Market Value, by Modality (2021-2033)
- 11.3.1 PET
- 11.3.2 CT
- 11.3.3 MRI
- 11.3.4 X-Ray
- 11.3.5 Ultrasound
- 11.3.6 Echocardiography
- 11.4 North America Clinical Trial Imaging Market Value, by Application (2021-2033)
- 11.4.1 Pharmaceutical
- 11.4.2 Biotechnology
- 11.4.3 Medical Devices
- 11.4.4 Others
- 11.5 North America Clinical Trial Imaging Market Value, by Services (2021-2033)
- 11.5.1 Operational Imaging Services
- 11.5.2 Trial Design Consulting Services
- 11.5.3 Read Analysis Services
Chapter 12 Europe Clinical Trial Imaging Market
- 12.1 Overview
- 12.2 Europe Clinical Trial Imaging Market Value, by Country (2021-2033)
- 12.2.1 UK
- 12.2.2 Germany
- 12.2.3 France
- 12.2.4 Spain
- 12.2.5 Italy
- 12.2.6 Russia
- 12.2.7 Rest of Europe
- 12.3 Europe Clinical Trial Imaging Market Value, by Modality (2021-2033)
- 12.3.1 PET
- 12.3.2 CT
- 12.3.3 MRI
- 12.3.4 X-Ray
- 12.3.5 Ultrasound
- 12.3.6 Echocardiography
- 12.4 Europe Clinical Trial Imaging Market Value, by Application (2021-2033)
- 12.4.1 Pharmaceutical
- 12.4.2 Biotechnology
- 12.4.3 Medical Devices
- 12.4.4 Others
- 12.5 Europe Clinical Trial Imaging Market Value, by Services (2021-2033)
- 12.5.1 Operational Imaging Services
- 12.5.2 Trial Design Consulting Services
- 12.5.3 Read Analysis Services
Chapter 13 Asia Pacific Clinical Trial Imaging Market
- 13.1 Overview
- 13.2 Asia Pacific Clinical Trial Imaging Market Value, by Country (2021-2033)
- 13.2.1 China
- 13.2.2 Japan
- 13.2.3 India
- 13.2.4 South Korea
- 13.2.5 Australia
- 13.2.6 Southeast Asia
- 13.2.7 Rest of Asia Pacific
- 13.3 Asia Pacific Clinical Trial Imaging Market Value, by Modality (2021-2033)
- 13.3.1 PET
- 13.3.2 CT
- 13.3.3 MRI
- 13.3.4 X-Ray
- 13.3.5 Ultrasound
- 13.3.6 Echocardiography
- 13.4 Asia Pacific Clinical Trial Imaging Market Value, by Application (2021-2033)
- 13.4.1 Pharmaceutical
- 13.4.2 Biotechnology
- 13.4.3 Medical Devices
- 13.4.4 Others
- 13.5 Asia Pacific Clinical Trial Imaging Market Value, by Services (2021-2033)
- 13.5.1 Operational Imaging Services
- 13.5.2 Trial Design Consulting Services
- 13.5.3 Read Analysis Services
Chapter 14 Latin America Clinical Trial Imaging Market
- 14.1 Overview
- 14.2 Latin America Clinical Trial Imaging Market Value, by Country (2021-2033)
- 14.2.1 Brazil
- 14.2.2 Argentina
- 14.2.3 Rest of Latin America
- 14.3 Latin America Clinical Trial Imaging Market Value, by Modality (2021-2033)
- 14.3.1 PET
- 14.3.2 CT
- 14.3.3 MRI
- 14.3.4 X-Ray
- 14.3.5 Ultrasound
- 14.3.6 Echocardiography
- 14.4 Latin America Clinical Trial Imaging Market Value, by Application (2021-2033)
- 14.4.1 Pharmaceutical
- 14.4.2 Biotechnology
- 14.4.3 Medical Devices
- 14.4.4 Others
- 14.5 Latin America Clinical Trial Imaging Market Value, by Services (2021-2033)
- 14.5.1 Operational Imaging Services
- 14.5.2 Trial Design Consulting Services
- 14.5.3 Read Analysis Services
Chapter 15 Middle East & Africa Clinical Trial Imaging Market
- 15.1 Overview
- 15.2 Middle East & Africa Clinical Trial Imaging Market Value, by Country (2021-2033)
- 15.2.1 Saudi Arabia
- 15.2.2 UAE
- 15.2.3 South Africa
- 15.2.4 Rest of Middle East & Africa
- 15.3 Middle East & Africa Clinical Trial Imaging Market Value, by Modality (2021-2033)
- 15.3.1 PET
- 15.3.2 CT
- 15.3.3 MRI
- 15.3.4 X-Ray
- 15.3.5 Ultrasound
- 15.3.6 Echocardiography
- 15.4 Middle East & Africa Clinical Trial Imaging Market Value, by Application (2021-2033)
- 15.4.1 Pharmaceutical
- 15.4.2 Biotechnology
- 15.4.3 Medical Devices
- 15.4.4 Others
- 15.5 Middle East & Africa Clinical Trial Imaging Market Value, by Services (2021-2033)
- 15.5.1 Operational Imaging Services
- 15.5.2 Trial Design Consulting Services
- 15.5.3 Read Analysis Services
Chapter 16 Company Profiles and Market Share Analysis: (Business Overview, Market Share Analysis, Products/Services Offered, Recent Developments)
- 16.1 Biotelemetry, Inc.
- 16.2 Cardiovascular Imaging Technologies, LLC
- 16.3 Radiant Sage LLC
- 16.4 Worldcare Clinical, LLC
- 16.5 Intrinsic Imaging LLC
- 16.6 Bioclinica, Inc.
- 16.7 Parexel International Corporation
- 16.8 Icon PLC
- 16.9 Biomedical Systems Corporation
- 16.10 Ixico PLC
- 16.11 Others
Related Reports
Report ID:
6
Published Date:
February 2025
Trusted by more than 10,500 organizations globally
Infaluble Methodology
Customization
Analyst Support
Targeted Market View